Macrophage polarization to a unique phenotype driven by B cells

European Journal of Immunology

Volumn 40, Issue 8, 2010, Pages 2296-2307

  Wong, Siew Cheng ^a   Puaux, Anne Laure ^a   Chittezhath, Manesh ^a   Shalova, Irina ^a   Kajiji, Tasneem S ^a   Wang, Xiaojie ^a   Abastado, Jean Pierre ^a   Lam, Kong Peng ^b   Biswas, Subhra K ^a  

^a AGENCY FOR SCIENCE   (Singapore)

^b AGENCY FOR SCIENCE   (Singapore)

Author keywords

B1 cells; Inflammation; M ; M2 polarization; Tumor

Indexed keywords

BETA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; RANTES; STAT1 PROTEIN; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CANCER IMMUNOLOGY; COCULTURE; CONTROLLED STUDY; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MELANOMA B16; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ADAPTIVE IMMUNITY; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, DIFFERENTIATION; B-LYMPHOCYTES; CELL COMMUNICATION; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; CYTOKINES; IMMUNITY, INNATE; MACROPHAGES; MELANOMA, EXPERIMENTAL; MICE; MICE, TRANSGENIC; NF-KAPPA B; TRANSCRIPTIONAL ACTIVATION;

EID: 77956114905     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200940288     Document Type: Article

References (44)

1. Goerdt, S. and Orfanos, C. E., Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999. 10: 137-142. (Pubitemid 29115619)
2. Li, A. C. and Glass, C. K., The macrophage foam cell as a target for therapeutic intervention. Nat. Med. 2002. 8: 1235-1242.
3. Mantovani, A., Schioppa, T., Biswas, S. K., Marchesi, F., Allavena, P. and Sica, A., Tumor-associated macrophages and dendritic cells as prototypic type II polarized myeloid populations. Tumori 2003. 89: 459-468. (Pubitemid 37541598)
4. Lewis, C. E. and Pollard, J. W., Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006. 66: 605-612.
5. Pollard, J. W., Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 2004. 4: 71-78.
6. Karin, M., Lawrence, T. and Nizet, V., Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006. 124: 823-835. (Pubitemid 43261455)
7. Biswas, S. K., Gangi, L., Paul, S., Schioppa, T., Saccani, A., Sironi, M., Bottazzi, B. et al., A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). Blood 2006. 107: 2112-2122.
8. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A. and Locati, M., The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004. 25: 677-686. (Pubitemid 39457982)
9. Mantovani, A., Sozzani, S., Locati,M., Allavena, P. and Sica, A., Macrophage polarization: tumor-associated macrophages as a paradigmfor polarized M2 mononuclear phagocytes. Trends Immunol. 2002. 23: 549-555. (Pubitemid 35223554)
10. Gordon, S., Alternative activation of macrophages. Nat. Rev. Immunol. 2003. 3: 23-35.
11. Anderson, C. F. and Mosser, D. M., A novel phenotype for an activated macrophage: the type 2 activated macrophage. J. Leukoc. Biol. 2002. 72: 101-106.
12. Mantovani, A., Sica, A. and Locati, M., Macrophage polarization comes of age. Immunity 2005. 23: 344-346.
13. Biswas, S. K., Sica, A. and Lewis, C. E., Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J. Immunol. 2008. 180: 2011-2017.
14. Stout, R. D. and Suttles, J., Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J. Leukoc. Biol. 2004. 76: 509-513.
15. Van Ginderachter, J. A., Movahedi, K., Hassanzadeh Ghassabeh, G., Meerschaut, S., Beschin, A., Raes, G. and De Baetselier, P., Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. Immunobiology 2006. 211: 487-501. (Pubitemid 44241651)
16. Loke, P., Nair, M. G., Parkinson, J., Guiliano, D., Blaxter, M. and Allen, J. E., IL-4 dependent alternatively activated macrophages have a distinctive in vivo gene expression phenotype. Biomed. Chromatogr. Immunol. 2002. 3: 7.
17. Hassanzadeh Ghassabeh, G., De Baetselier, P., Brys, L., Noel, W., Van Ginderachter, J. A., Meerschaut, S., Beschin, A. et al., Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo during different pathologies. Blood 2006. 108: 575-583.
18. Noel, W., Raes, G., Hassanzadeh Ghassabeh, G., De Baetselier, P. and Beschin, A., Alternatively activated macrophages during parasite infections. Trends Parasitol. 2004. 20: 126-133. (Pubitemid 38264445)
19. de Visser, K. E., Korets, L. V. and Coussens, L. M., De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 2005. 7: 411-423.
20. Mantovani, A., Cancer: inflammation by remote control. Nature 2005. 435: 752-753.
21. Kipps, T. J., The CD5 B cell. Adv. Immunol. 1989. 47: 117-185.
22. Montecino-Rodriguez, E. and Dorshkind, K., New perspectives in B-1 B cell development and function. Trends Immunol. 2006. 27: 428-433. (Pubitemid 44216193)
23. Rothstein, T. L. and Kolber, D. L., Peritoneal B cells respond to phorbol esters in the absence of co-mitogen. J. Immunol. 1988. 140: 2880-2885.
24. Rothstein, T. L. and Kolber, D. L., Anti-Ig antibody inhibits the phorbol ester-induced stimulation of peritoneal B cells. J. Immunol. 1988. 141: 4089-4093.
25. Wong, S. C., Chew, W. K., Tan, J. E., Melendez, A. J., Francis, F. and Lam, K. P., Peritoneal CD5+B-1 cells have signaling properties similar to tolerant B cells. J. Biol. Chem. 2002. 277: 30707-30715.
26. Alugupalli, K. R. and Gerstein, R. M., Divide and conquer: division of labor by B-1 B cells. Immunity 2005. 23: 1-2.
27. Hasan, M., Polic, B., Bralic, M., Jonjic, S. and Rajewsky, K., Incomplete block of B cell development and immunoglobulin production in mice carrying the muMT mutation on the BALB/c background. Eur. J. Immunol. 2002. 32: 3463-3471.
28. Lam, K. P. and Rajewsky, K., B cell antigen receptor specificity and surface density together determine B-1 versus B-2 cell development. J. Exp. Med. 1999. 190: 471-477.
29. Kawai, T., Takeuchi, O., Fujita, T., Inoue, J., Muhlradt, P. F., Sato, S., Hoshino, K. and Akira, S., Lipopolysaccharide stimulates the MyD88- independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 2001. 167: 5887-5894. (Pubitemid 33062783)
30. Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O. et al., Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003. 301: 640-643. (Pubitemid 36927946)
31. Gary-Gouy, H., Harriague, J., Bismuth, G., Platzer, C., Schmitt, C. and Dalloul, A. H., Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production. Blood 2002. 100: 4537-4543.
32. Murray, P. J., Understanding and exploiting the endogenous interleukin- 10/STAT3-mediated anti-inflammatory response. Curr. Opin. Pharmacol. 2006. 6: 379-386.
33. Sironi, M., Martinez, F. O., D'Ambrosio, D., Gattorno, M., Polentarutti, N., Locati, M., Gregorio, A. et al., Differential regulation of chemokine production by Fcgamma receptor engagement in human monocytes: association of CCL1 with a distinct form of M2 monocyte activation (M2b, Type 2). J. Leukoc. Biol. 2006. 80: 342-349. (Pubitemid 44835507)
34. Martinez, F. O., Gordon, S., Locati, M. and Mantovani, A., Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 2006. 177: 7303-7311. (Pubitemid 44715100)
35. Hacker, H., Redecke,V., Blagoev, B., Kratchmarova, I., Hsu, L.C., Wang, G.G., Kamps, M. P. et al., Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 2006. 439: 204-207.
36. Chang, E. Y., Guo, B., Doyle, S. E. and Cheng, G., Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production. J. Immunol. 2007. 178: 6705-6709. (Pubitemid 46847391)
37. Andreu, P., Johansson, M., Affara, N. I., Pucci, F., Tan, T., Junankar, S., Korets, L. et al., FcRgamma activation regulates inflammation-associated squamous carcinogenesis. Cancer Cell 2010. 17: 121-134.
38. Mantovani, A., Allavena, P., Sica, A. and Balkwill, F., Cancer-related inflammation. Nature 2008. 454: 436-444.
39. Sica, A. and Bronte, V., Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Invest. 2007. 117: 1155-1166.
40. Perricone, M. A., Smith, K. A., Claussen, K. A., Plog, M. S., Hempel, D. M., Roberts, B. L., St George, J. A. and Kaplan, J. M., Enhanced efficacy of melanoma vaccines in the absence of B lymphocytes. J. Immunother. 2004. 27: 273-281.
41. Parkes, H., Collis, P., Baildam, A., Ralphs, D., Lyons, B., Howell, A. and Craig, R., In situ hybridisation and S1 mapping show that the presence of infiltrating plasma cells is associated with poor prognosis in breast cancer. Br. J. Cancer 1988. 58: 715-722.
42. Watkins, S. K., Egilmez, N. K., Suttles, J. and Stout, R. D., IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo. J. Immunol. 2007. 178: 1357-1362.
43. Sakamoto, N., Shibuya, K., Shimizu, Y., Yotsumoto, K., Miyabayashi, T., Sakano, S., Tsuji, T. et al., A novel Fc receptor for IgA and IgM is expressed on both hematopoietic and non-hematopoietic tissues. Eur. J. Immunol. 2001. 31: 1310-1316.
44. Shibuya, A., Sakamoto, N., Shimizu, Y., Shibuya, K., Osawa, M., Hiroyama, T., Eyre, H. J. et al., Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes. Nat. Immunol. 2000. 1: 441-446.